+499.5%
MRNA vs FFIV
+25.9%
+473.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FFIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -2.3% |
| 7D | +5.5% | -1.0% | +6.4% | +5.3% |
| 30D | +158.7% | -5.1% | +163.8% | +161.7% |
| 3M | +182.1% | -4.5% | +186.6% | +184.7% |
| 6M | +151.8% | +36.5% | +115.3% | +125.3% |
| YTD | +393.6% | +53.0% | +340.6% | +318.0% |
| 1Y | +499.5% | +24.2% | +475.2% | +401.8% |
| All | +499.5% | +25.9% | +473.6% | +401.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FFIV.
Daily Out/Under-Performance
Portfolio return minus FFIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FFIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FFIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling